Article
CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptors
2021-07-11
Abstract excerpt
CD19-targeted CAR therapies have successfully treated B cell leukemias and lymphomas, but many responders later relapse or experience toxicities. CAR intracellular domains (ICDs) are key to converting antigen recognition into anti-tumor effector functions. Despite the many possible immune signaling domain combinations that could be included in CARs, almost all CARs currently rely upon CD3 ζ , CD28, and/or 4-1BB s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ec8b3d4b-d05e-5c52-9c88-5ce82b2fb04b
- DOI
- 10.1101/2021.07.09.450900
